Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
HILZ MARK T | COO, Secretary and Director, Director | C/O HEARTSCIENCES INC.,, 550 RESERVE STREET, SUITE 360, SOUTHLAKE | /s/ Mark Hilz | 2025-07-30 | 0001016157 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HSCS | Common Stock, $0.001 par value | Sale | -$15.6K | -4.42K | -48.17% | $3.54 | 4.75K | Jul 29, 2025 | Direct | F1, F2 |
holding | HSCS | Common Stock, $0.001 par value | 41 | Jul 29, 2025 | See footnote | F3 |
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2025. |
F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.52 to $3.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
F3 | Represents shares held by the Reporting Person's daughter. |